Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study
Zhi‐Qiang Wang, De‐Shen Wang, Feng‐Hua Wang, Chao Ren, Qiong Tan, Yuhong Li
Topics & Concepts
NedaplatinMedicineInternal medicineRegimenClinical endpointPhases of clinical researchOncologyEndostatinPaclitaxelAdverse effectGastroenterologyProgression-free survivalSurgeryChemotherapyClinical trialAngiogenesisCisplatinEsophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesAngiogenesis and VEGF in Cancer